A new oral anticoagulant hits the market
Pradaxa gives clinicians a new tool for preventing strokes and blood clots in patients with atrial fibrillation. Learn how it works, who’s eligible to…
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.